Biocon, Mylan enters into an in-licensing deal with Fujifilm
Biocon’s partner Mylan, has entered into an in-licensing deal to speed up commercialization of biosimilar Humira, developed by Fujifilm Kyowa Kirin Biologics for European markets. Adalimumab...
